Publications by authors named "Patrick Turko"

Claim this Profile
T
The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individuals.
Yasser Morsy, Barbara Hubeli, Patrick Turko, Marjam Barysch, Julia M Martínez-Gómez

Cell Rep Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p.
Paulina Hennig, Patrick Turko, Michela Di Filippo, Mitchell P Levesque, Thomas Kündig

Cell Death Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients.
Ramon Staeger, Aizhan Tastanova, Adhideb Ghosh, Nicola Winkelbeiner, Prachi Shukla, Patrick Turko

J Clin Invest· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for analysis of miRNAs in human melanoma cells.
Evelyn Lattmann, Tessa Guggiari, Patrick Turko, Mitchell P Levesque

STAR Protoc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.
Lukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, Ramon Staeger, Adhideb Ghosh

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma Cells.
Alessandra S P Cereghetti, Patrick Turko, Phil Cheng, Stephan Benke, Ala'a Al Hrout

JID Innov· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CTLA4 treatment reduces lymphedema risk potentially through a systemic expansion of the FOXP3 T population.
Stefan Wolf, Matiar Madanchi, Patrick Turko, Maija Hollmén, Sonia Tugues

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.
Mauro Esposito, Laura Yerly, Prachi Shukla, Victoria Hermes, Federica Sella, Patrick Turko

Br J Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes.
Cadri Knoch, Veronika Baghin, Patrick Turko, Nicola Winkelbeiner, Ramon Staeger

Int J Mol Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of radiological response to tebentafusp in patients with metastatic uveal melanoma.
Natalia M Roshardt Prieto, Patrick Turko, Caroline Zellweger, Thi Dan Linh Nguyen-Kim, Ramon Staeger

Melanoma Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.
Ramon Staeger, Julia M Martínez-Gómez, Patrick Turko, Egle Ramelyte, Lukas Kraehenbuehl

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma.
Lorenza P Ferretti, Flurina Böhi, Deena M Leslie Pedrioli, Phil F Cheng, Elena Ferrari, Patrick Turko

Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production.
Marlene Langenbach, Sophie Giesler, Stefan Richtsfeld, Sara Costa-Pereira, Lukas Rindlisbacher, Patrick Turko

Mol Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma.
Fabienne Fröhlich, Egle Ramelyte, Patrick Turko, Andreas Dzung, Sandra N Freiberger

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.
Alexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko

J Eur Acad Dermatol Venereol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma.
Ossia M Eichhoff, Corinne I Stoffel, Jan Käsler, Luzia Briker, Patrick Turko

Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma.
Aurelio Boerlin, Elisa Bellini, Patrick Turko, Phil F Cheng, Mitchell P Levesque

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression.
Annalisa Saltari, Andreas Dzung, Marika Quadri, Natascia Tiso, Nicola Facchinello, Patrick Turko

Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Unfrozen Storage and Repeated Freeze-Thawing of SARS-CoV-2 Patient Samples Have Minor Effects on SARS-CoV-2 Detectability by RT-PCR.
Andreas Dzung, Phil F Cheng, Corinne Stoffel, Aizhan Tastanova, Patrick Turko

J Mol Diagn· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.
Melike Ak, Abdullah Kahraman, Fabian M Arnold, Patrick Turko, Mitchell P Levesque

Genes (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who's Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma.
Sandra N Freiberger, Patrick Turko, Martin Hüllner, Reinhard Dummer, Grégoire B Morand

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective.
Egle Ramelyte, Aizhan Tastanova, Zsolt Balázs, Desislava Ignatova, Patrick Turko

Cancer Cell· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma Growth.
Ikrame Lazar, Bertrand Fabre, Yongmei Feng, Ali Khateb, Patrick Turko

Mol Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma.
Sandra N Freiberger, Grégoire B Morand, Patrick Turko, Ulrich Wager, Reinhard Dummer

Cancers (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma patients with additional primary cancers: a single-center retrospective analysis.
Florentia Dimitriou, Joanna Mangana, Alessandra Curioni-Fontecedro, Markus Rechsteiner, Patrick Turko

Oncotarget· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis